Deuterated 21-[4-Cyanopyrazol-1-yl]-19-nor-pregan-3-alpha-ol-20-one derivatives for the treatment of central nervous system disorders

MA51046AUndetermined Publication Date: 2021-03-17SAGE THERAPEUTICS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MA51046
Authority / Receiving Office
MA · MA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2018-09-14
Filing Date
2018-12-07
Publication Date
2021-03-17
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.